Olfactory dysfunction is now recognized as one of the earliest and most prominent preclinical markers of Alzheimer's disease (AD), often appearing 10-20 years before clinical diagnosis. The olfactory system is uniquely vulnerable to AD pathology due to the early accumulation of amyloid-beta plaques and neurofibrillary tangles in olfactory-related brain regions, making olfactory testing a valuable non-invasive screening tool.
The olfactory deficits in AD result from:
| Disease Stage | Olfactory Changes |
|---|---|
| Preclinical | Subtle odor identification deficits, normal threshold |
| MCI | Impaired odor identification and discrimination |
| Mild AD | Reduced odor memory, olfactory threshold changes |
| Moderate-Severe | Anosmia or severe hyposmia |
The UPSIT is a 40-item scratch-and-sniff test widely used in research and clinical settings:
Diagnostic Performance for AD:
A three-part test assessing threshold, discrimination, and identification (TDI):
TDI Score Interpretation:
MRI-based measurement of olfactory bulb volume serves as an imaging biomarker:
White matter integrity in olfactory pathways:
| Olfactory Biomarker | Sensitivity | Specificity | AUC | Cost |
|---|---|---|---|---|
| UPSIT (<30) | 78% | 72% | 0.81 | $20-30 |
| Sniffin' Sticks TDI | 75% | 70% | 0.79 | $25-40 |
| Olfactory bulb MRI | 74% | 68% | 0.76 | $500-1000 |
| Combined testing | 85% | 78% | 0.88 | $50-100 |
Japanese:
Korean:
Chinese:
Olfactory biomarkers align with neurodegeneration (N) category:
Combining olfactory with other biomarkers improves accuracy:
| Biomarker Combination | AUC |
|---|---|
| Olfactory + p-Tau181 | 0.89 |
| Olfactory + MRI atrophy | 0.87 |
| Olfactory + cognitive tests | 0.85 |
Portable olfactometers — Home-based threshold testing[28]
Electroolfactogram — Objective olfactory response measurement[29]
Olfactory nanoparticle detection — Emerging biomarker technology[30]
AI-integrated analysis — Machine learning for multimodal olfactory data[31]
Talamo et al. Olfactory pathology in Alzheimer's disease. Annals of the New York Academy of Sciences. 1989. ↩︎
Braak & Braak. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica. 1991. ↩︎
Wang et al. Piriform cortex in Alzheimer's disease. Neuroimage. 2011. ↩︎
Hawkes. Olfaction and neurodegenerative disease. QJM. 2003. ↩︎
Doty et al. UPSIT:smell identification test. Clinical Therapeutics. 1984. ↩︎
Conti et al. Olfactory testing for Alzheimer's disease. Journal of Alzheimer's Disease. 2013. ↩︎
Hummel et al. Sniffin' Sticks: a practical olfactory test. European Archives of Oto-Rhino-Laryngology. 2007. ↩︎
Djordjevic et al. Olfactory deficits in mild cognitive impairment. Journal of Neurology, Neurosurgery & Psychiatry. 2008. ↩︎
Moon & Kim. Korean version of UPSIT. Korean Journal of Otorhinolaryngology-Head and Neck Surgery. 2011. ↩︎
Saito et al. Japanese olfactory test. Allergy and Immunology. 2006. ↩︎
Schriever et al. Cross-cultural olfactory test validation. PLoS ONE. 2014. ↩︎
Yousem et al. MR olfactory bulb imaging. Radiology. 1998. ↩︎
Thomann et al. Olfactory bulb volume in AD. Journal of Alzheimer's Disease. 2009. ↩︎
Han et al. Olfactory bulb volume predicts MCI progression. Journal of Alzheimer's Disease. 2015. ↩︎
Son et al. DTI of olfactory pathways in AD. Neuroradiology. 2015. ↩︎
Chen et al. White matter changes in olfactory system. Neurobiology of Aging. 2015. ↩︎
Moscatelli et al. FDG-PET olfactory cortex metabolism. Journal of Nuclear Medicine. 2011. ↩︎
Ohnishi et al. PiB PET in olfactory bulb. Journal of Alzheimer's Disease. 2015. ↩︎
Saito et al. Japanese UPSIT validation. Allergy. 2007. ↩︎
Nunez et al. Japanese olfactory bulb MRI norms. PLOS ONE. 2014. ↩︎
Kim et al. K-UPSIT diagnostic performance. Journal of Clinical Neurology. 2014. ↩︎
Park et al. Korean olfactory-sleep study. Sleep Medicine. 2017. ↩︎
Zhang et al. Chinese olfactory test development. PLOS ONE. 2015. ↩︎
Lin et al. Olfactory dysfunction in Chinese MCI/AD. Journal of Alzheimer's Disease. 2017. ↩︎
Ruan et al. Olfactory biomarkers and CSF markers. Neurobiology of Aging. 2016. ↩︎
Velayudhan et al. Olfactory prediction of amyloid positivity. Journal of Alzheimer's Disease. 2013. ↩︎
Pereira et al. Multi-marker olfactory staging. Brain. 2018. ↩︎
Dalton et al. Home olfactory testing devices. Chemical Senses. 2013. ↩︎
Lapair et al. Electroolfactogram in neurodegenerative disease. Otolaryngology-Head and Neck Surgery. 2014. ↩︎
Pezzuto et al. Olfactory nanoparticles as biomarkers. Nanomedicine. 2016. ↩︎
Scott et al. Machine learning olfactory analysis. Scientific Reports. 2018. ↩︎